Benvenuti M, Albanese L, Pagliara L
Minerva Med. 1983 Jun 23;74(26):1563-8.
Fifty outpatients suffering from rheumatoid disorders were treated with proglumetacin. Efficacy was classified as "good" or "very good" in 80% of cases. Besides this considerable efficacy, a tolerance classified as "good" or "very good" was observed in 86% of patients.